$BCLI·4

BRAINSTORM CELL THERAPEUTICS INC. · Jun 23, 5:05 PM ET

BRAINSTORM CELL THERAPEUTICS INC. 4

4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Jun 23, 2016

Insider Transaction Report

Form 4
Period: 2016-06-22
Pinkas Alon
Director
Transactions
  • Award

    Stock Option (right to buy)

    2016-06-22+15,33315,333 total
    Exercise: $0.75From: 2016-07-22Exp: 2026-06-22Common Stock (15,333 underlying)
Footnotes (1)
  • [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on July 22, 2016 until fully vested and exercisable on June 22, 2017, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.

Documents

1 file
  • 4
    v442782_4.xmlPrimary

    OWNERSHIP DOCUMENT